EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY-NC-ND 4.0

Gasdermin‐Mediated Pyroptosis: Novel Strategies Against Colorectal Cancer

Kaibo Guo iD, Yuqian Feng, Jiamin Lu, Nuerbiye Abudurexiti, Xinlei Zhou, Mengfan Wei, Song Zheng iD

Cancer Science · 2026

DOI: 10.1111/cas.70426 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Cancer Science, 2026. Verfasst von Kaibo Guo und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Oncology, Affiliated Hangzhou First People's Hospital, School of Medicine, Westlake University, Hangzhou, China. Hauptthemen laut MEDLINE: Pyroptosis, Colorectal Neoplasms, Neoplasm Proteins. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 179 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Natural Science Foundation of Zhejiang Province, Medical and Health Technology Program of Zhejiang Province, National Natural Science Foundation of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Pyroptosis, a form of programmed cell death mediated by gasdermin proteins, has gained attention for its dual role in colorectal cancer (CRC) progression and therapy. While chronic pyroptosis‐driven inflammation can promote tumorigenesis, acute induction of pyroptosis in tumor cells offers promising antitumor effects. Understanding the mechanisms and implications of pyroptosis in CRC could lead to novel therapeutic strategies. Gasdermin proteins, particularly GSDMD and GSDME, are central to pyroptotic processes in CRC. GSDMD activation, often through NLRP3 inflammasome signaling or chemotherapeutic agents like simvastatin, induces pyroptosis and modulates immune infiltration. Conversely, GSDMC has been implicated in CRC progression under metabolic stress by recruiting immunosuppressive cells. Although frequently silenced in CRC, GSDME enhances sensitivity to chemoradiation and synergizes with immune checkpoint inhibitors by releasing immunostimulatory molecules. Inflammasomes, notably NLRP3 and AIM2, also play significant roles in CRC pathogenesis through pyroptosis and cytokine secretion. NLRP3 activation exacerbates tumor growth via inflammatory pathways, while AIM2 exerts tumor‐suppressive effects, especially in BRAF‐mutant CRC. The gut microbiota further influences inflammasome activity, with certain strains promoting chemoresistance and others enhancing antitumor immunity. Therapeutically, inducing pyroptosis synergizes with conventional therapies and immunotherapies, overcoming apoptosis resistance and resensitizing tumors. Pyroptosis releases tumor antigens and damage‐associated molecular patterns, recruiting cytotoxic lymphocytes and natural killer cells, thereby remodeling the immunosuppressive microenvironment. Pyroptosis represents a double‐edged sword in CRC, offering both challenges and opportunities. Harnessing its antitumor potential while mitigating pro‐tumorigenic inflammation requires innovative strategies. Future research should focus on elucidating the isoform‐specific roles of gasdermins, optimizing therapeutic approaches to induce pyroptosis.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

PyroptosisColorectal NeoplasmsNeoplasm ProteinsHumansGasderminsInflammasomesNLR Family, Pyrin Domain-Containing 3 ProteinAnimalsIntracellular Signaling Peptides and ProteinsPhosphate-Binding ProteinsSignal TransductionDNA-Binding ProteinsReceptors, Estrogen

Stichwörter der Autor:innen

colorectal cancer immunotherapygasdermin familyinflammasome activationpyroptosistumor microenvironment remodeling

Substanzen

GasderminsInflammasomesNLR Family, Pyrin Domain-Containing 3 ProteinGSDME protein, humanIntracellular Signaling Peptides and ProteinsPhosphate-Binding ProteinsGSDMD protein, humanNLRP3 protein, humanNeoplasm ProteinsDNA-Binding Proteins

Autor:innen und Institutionen

  • Department of Oncology, Affiliated Hangzhou First People's Hospital, School of Medicine, Westlake University, Hangzhou, China.
  • Key Laboratory of Clinical Cancer Pharmacology & Toxicology Research of Zhejiang Province, Affiliated Hangzhou First People's Hospital, School of Medicine, Westlake University, Hangzhou, China.
  • Department of Geriatrics, The First Affiliated Hospital of Zhejiang Chinese Medical University (Zhejiang Provincial Hospital of Traditional Chinese Medicine), Hangzhou, China.
  • Department of Oncology, The First Affiliated Hospital of Zhejiang Chinese Medical University (Zhejiang Provincial Hospital of Traditional Chinese Medicine), Hangzhou, China.
  • Department of Oncology, the Fourth School of Clinical Medicine, Zhejiang Chinese Medical University, Hangzhou, China.
  • The Third Clinical Medical School, the Rehabilitation Medical School, Zhejiang Chinese Medical University, Hangzhou, China.

ORCID-Profile: Kaibo Guo, Song Zheng

Förderung

  • Natural Science Foundation of Zhejiang Province
  • Medical and Health Technology Program of Zhejiang Province
  • National Natural Science Foundation of China
  • Traditional Chinese Medicine Science and Technology Program of Zhejiang Province

Zitieren

APA

Guo, K., Feng, Y., Lu, J., Abudurexiti, N., Zhou, X., Wei, M., & Zheng, S. (2026). Gasdermin‐Mediated Pyroptosis: Novel Strategies Against Colorectal Cancer. Cancer Science. https://doi.org/10.1111/cas.70426

Vancouver

Guo K, Feng Y, Lu J, Abudurexiti N, Zhou X, Wei M, et al. Gasdermin‐Mediated Pyroptosis: Novel Strategies Against Colorectal Cancer. Cancer Science. 2026. doi:10.1111/cas.70426

BibTeX
@article{Guo2026,
  author = {Guo, Kaibo and Feng, Yuqian and Lu, Jiamin and Abudurexiti, Nuerbiye and Zhou, Xinlei and Wei, Mengfan and Zheng, Song},
  title = {Gasdermin‐Mediated Pyroptosis: Novel Strategies Against Colorectal Cancer},
  journal = {Cancer Science},
  year = {2026},
  doi = {10.1111/cas.70426}
}
Kostenlos starten →